Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis

被引:8
|
作者
Lubrano, Ennio [1 ,2 ]
Scriffignano, Silvia [1 ]
Perrotta, Fabio Massimo [1 ]
机构
[1] Univ Molise, Dipartimento Med & Sci Salute Vincenzo Tiberio, Acad Rheumatol Unit, Via Giovanni Paolo II, I-86100 Campobasso, Italy
[2] KU Leuven Univ, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Leuven, Belgium
关键词
Psoriatic arthritis; Treatment; Difficult to treat; Refractory; MINIMAL DISEASE-ACTIVITY;
D O I
10.1007/s40744-023-00574-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriatic arthritis (PsA) is a complex and chronic inflammatory condition in which the achievement of the best possible disease control has been proposed as the treatment target, which includes the possibility of reaching remission in all disease domains. However, due to the complexity of this multidomain disease, some patients may still have high disease activity in one or more domain and a high burden of disease, potentially leading to various treatment changes and to difficulty with the overall management. In this paper, we overview the concept of patients with difficult-to-treat PsA and the concept of patients with refractory-to-treatment PsA by providing a distinction between these two concepts and the possible implication for the management of patients with PsA.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 50 条
  • [1] Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
    Ennio Lubrano
    Silvia Scriffignano
    Fabio Massimo Perrotta
    [J]. Rheumatology and Therapy, 2023, 10 : 1119 - 1125
  • [2] Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis
    Graceffa, D.
    Sperati, F.
    Lora, V.
    Orsini, D.
    Spoletini, G.
    Bonifati, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [3] CHARACTERISTICS OF DIFFICULT TO TREAT PSORIATIC ARTHRITIS: A COMPARATIVE ANALYSIS
    Philippoteaux, C.
    Marty-Ane, A.
    Martin, C.
    Philippe, P.
    Paccou, J.
    Cortet, B.
    Flipo, R. M.
    Letarouilly, J. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1121 - 1121
  • [4] Abatacept as an option therapy in difficult to treat psoriatic arthritis
    Francisco José Fernandes Vieira
    Maria Roseli Monteiro Callado
    Walber Pinto Vieira
    [J]. Rheumatology International, 2010, 30 : 849 - 850
  • [5] Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
    Fagni, Filippo
    Motta, Francesca
    Schett, Georg
    Selmi, Carlo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2024, 76 (05) : 670 - 674
  • [6] Abatacept as an option therapy in difficult to treat psoriatic arthritis
    Fernandes Vieira, Francisco Jose
    Monteiro Callado, Maria Roseli
    Vieira, Walber Pinto
    [J]. RHEUMATOLOGY INTERNATIONAL, 2010, 30 (06) : 849 - 850
  • [7] Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
    Philippoteaux, Cecile
    Marty-Ane, Anne
    Cailliau, Emeline
    Labreuche, Julien
    Philippe, Peggy
    Cortet, Bernard
    Paccou, Julien
    Flipo, Rene-Marc
    Letarouilly, Jean-Guillaume
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [8] Characteristics of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
    Philippoteaux, Cecile
    Marty-Ane, Anne
    Cailliau, Emeline
    Philippe, Peggy
    Cortet, Bernard
    Paccou, Julien
    Flipo, Rene-Marc
    Letarouilly, Jean-Guillaume
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1560 - 1562
  • [9] Difficult to treat psoriatic arthritis — how should we manage?
    Anand Kumthekar
    Maedeh Ashrafi
    Atul Deodhar
    [J]. Clinical Rheumatology, 2023, 42 : 2251 - 2265
  • [10] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
    Siebert, Stefan
    Marzo-Ortega, Helena
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (03) : 135 - 136